With FDA Approval, Icotyde Wades Into Competitive Psoriasis Market

 
• By Alaric DeArment
  
The FDA approved Icotyde for moderate-to-severe plaque psoriasis. (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip